| Tag | Content |
|---|
EnhancerAtlas ID | HS091-23540 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr19:17493140-17495160 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr19:17495032-17495051 | TGACCAGCAGAGGGCGGGT | + | 6.35 | | Nr2f6(var.2) | MA0728.1 | chr19:17494240-17494255 | TGAACTCCTGACCTC | - | 6.22 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_53869 | chr19:17493007-17494406 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I017382 | chr19 | 17493200 | 17494644 |
|
Enhancer Sequence | TGAATGAAAT TACTGGGTCT CAAAGTGGGC ACATTTTTAC ATTTTGATAG TTGTCACCAA 60
TTTGTCCTTC AAAGAGGTTG TTTTCATTGA CATCTTTGCC TGCGATGTCT GAAATCTCCA 120
AACATGGACT TTATGAAAAT GTTCTGTTTG TGTCCTTGGC CAGAAAAATC TGGAGGGAGA 180
ATGTGAGTGC CTGATCAAGA ATCTACATGA AGTCAAATGC ATCAGCCCTG ATGTGAGTGT 240
TGGGTTTTTT CCTGAAAACA ATTTGTCATG TTCACAGGAA ATTTTGCACA TGAATCCCTT 300
CAAATTCCCT TGGAGGGGCA TCAGAAAATC AGGCTTGCTT TTTAAACCCT TTTGTTTTTC 360
TAAACAGAAA ACAATTGATT TGGTTTCATT TGTTTGTTTG AGTGGAGAAG GAAAAACTGT 420
CATGAGGAAG TCAACTCTGT GTCACTCCCT GAAAACTGAC ACTGAAGTCC TCATGGAGAC 480
ACGAGTTAAA AAAAAACAAA ATCACTCAGA ACTTCAGGAA GGTCCTTGAG GAAGTGATAT 540
TTCTGGTGAA GAAGGATTTC AGTGAAGTTC AGAAAACCTT CCACTATTTT GTTTTTTTTT 600
TTTTGAGACG GAGTGTTGCG CTGTTGCCCA GGCTGGAGTG CAGTGGCACG ATCTTGGCTC 660
ACTGCAAGCT CCGCCTCCTT CCGGGTTCAT GCCATTCTCC TGCTTCAGCC TCTAGAGTAG 720
CTGGGGACTA CAGGCTAATT TTTTGTGCCT TTAGTAGAGA TGGGGTTTCA CCGTGTTAGC 780
CAGGATGGTC TCGATCTCCT GACCTCGTGA TCCACCCACC TCGGCCTCCC AAAGTGCTAG 840
GATTACAGGC GTGAGCCCCT GCGCCTGGCT TTTTTTTTTC TTTTTCTTTT TTTGTTTTTT 900
TTGAGACGGA GTCTCGCTCT GTCGCCCAGG CTGGAGTGCA GTGGCGCCAT TTCGGCTCAC 960
TGCAACCTCT GTCTCCCAGG TTAGAGCAAT TCTGGCTCAG CCTCCTAAGT AGATGGGACT 1020
ACAGGTACAC ACTACCACCC CCGGCTAATT GTTATATTTT TAATAGAGAC TGGGTTTCAC 1080
CATATTGGAC AGACTGGTCT TGAACTCCTG ACCTCAAGTG ATCCTCCTAA CTCAGCCTCC 1140
CAAAATGCTG GGATTACAGG CATTAGCCAC TGCACCGGGC CAACCCTCCA CTTTTATGTC 1200
TGTGAGTTTG GTTTTTGGTT AATCGAAGTG AAGTTAAGTT TTGTGCTTTT GGAGGTGACG 1260
GAGGCAGCGA AGAGAGTCCC TCTGTGGGGT GGGGGAAACC TGTGCTCTCT GGGACTCTGT 1320
GTTCCCTGCT GAAAAACAGG GACCTAGGCT GGGCGTGGTG GCTCACGCCT GTAATCCCAG 1380
CACTTTGGGA GGCTGAGGCA GGCAGATCAC CTGAGGCCAG GAGTTTGAGA CCACCCTGAC 1440
CAACATGGAG AAACCCCGTC TCTACTAAAA ATACAAAACT AGCCAAGTGT CCTGGCGCAT 1500
GCCTGTAATC CCAGCACTGG GGAGGCTGAG GCAGAAGAAT CGCTTAAACC CGGGAGGTGG 1560
AGGTTGCAGT GAGCTGAGAC TGCGCCATTG CACTCCAGCC TGGGCAACAA CAGTGAAACT 1620
CGGTGTCATA AATAAATAAA TAAATAAAAA GAAAAACAGG GACCTACTTC CTTGCCTGTG 1680
ACTGGAGGGC TGGAAAGGTC AGGTTGCAAC TAGCCCATGT CCCCTCCTGC CAAGGCCACT 1740
GTGGGCTTTC CATTTTTGTC CCCTACCCCT GTCCCTCCAG CTATGGGAGG GGAGGTCCAG 1800
TGTGGCCACG GATAGGGATT ACCCAGGATG GTGCCCTGGA GACAGGGGTA GACAGACAGA 1860
GATAACCAGA GACAGAAAGA CACTTAAAGA GATGACCAGC AGAGGGCGGG TGCTGTTGCT 1920
CACGCCTGTA ATCCCAGCAC TTTGGGAGGC CGATGCAGGT GAATCACCTG AGGTCAGGAG 1980
TTCGAAACCA GCCTGGCCCA ACATGGTGAA ACCCTGTCTC 2020
|
